Antibiotic Treatment During Pregnancy and the First Six Months Postpartum – a Secondary Analysis of the “Healthy Living in Pregnancy” (GeliS) Study

Abstract

Introduction

Antibiotic therapies for the treatment of bacterial infections pose a particular challenge during pregnancy and breastfeeding. For Germany, there is hardly any information on the frequency of antibiotic use during this phase. Our analysis uses data from the “Healthy Living in Pregnancy” (GeliS) study to describe antibiotic treatments during pregnancy and in the first six months after birth (postpartum), and to compare their use with existing recommendations.

Methods

This is a retrospective secondary analysis of the GeliS study. In the cluster randomized lifestyle intervention study, detailed information on antibiotic therapies during pregnancy and postpartum was collected using surveys. Chi-square tests and generalized estimating equations were used for evaluation.

Results

Of the 1636 women included in the analysis, 21% reported antibiotic treatment at least once during pregnancy (14%) or in the first six months postpartum (7%). During pregnancy, the antibiotic therapies of women increased from 1.7% in the first trimester to 6.5% in the third trimester. Common reasons for treatment were urinary tract infections (7.3% of women), ear, nose, throat (ENT) infections (3.6%), and birth complications (2.6%). The information on the prescribed preparations corresponded to the current recommendations. A significant increase in the frequency of treatment with antibiotics was observed in the lifestyle intervention group (p < 0.001), in participants without a partner (p < 0.001), and in women who breastfed their children (p = 0.005) or gave birth by caesarean section (p = 0.003) or prematurely (p = 0.012). Other socioeconomic or lifestyle factors were not significant.

Conclusion

Approximately one in five women receives at least one antibiotic treatment during pregnancy and breastfeeding that meets current treatment recommendations. Treatment with antibiotics is more common in premature births, caesarean sections, and breastfeeding women.

Keywords

antibiotics - infection - pregnancy - breastfeeding

Publication History

Received: 12 November 2022

Accepted after revision: 06 May 2023

Article published online:
03 July 2023

• References/Literatur

• 1 Makati Medical Center. 10 Most Prescribed Medicines Around the World and Their Uses. 18.02.2022 Accessed October 08, 2022 at: https://www.makatimed.net.ph/blogs/10-most-prescribed-medicines/
• 2 Barriere SL. Clinical, economic and societal impact of antibiotic resistance. Expert Opin Pharmacother 2015; 16: 151-153 DOI: 10.1517/14656566.2015.983077. (PMID: 25483564)
• 3 Zanichelli V, Tebano G, Gyssens IC. et al. Patient-related determinants of antibiotic use: a systematic review. Clin Microbiol Infect 2019; 25: 48-53 DOI: 10.1016/j.cmi.2018.04.031. (PMID: 29777927)
• 4 Mukhopadhyay S, Sengupta S, Puopolo KM. Challenges and opportunities for antibiotic stewardship among preterm infants. Arch Dis Child Fetal Neonatal Ed 2019; 104: F327-F332 DOI: 10.1136/archdischild-2018-315412. (PMID: 30425110)
• 5 Bookstaver PB, Bland CM, Griffin B. et al. A Review of Antibiotic Use in Pregnancy. Pharmacotherapy 2015; 35: 1052-1062 DOI: 10.1002/phar.1649. (PMID: 26598097)
• 6 Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study. Br J Clin Pharmacol 2017; 83: 2557-2571 DOI: 10.1111/bcp.13364. (PMID: 28722171)
• 7 Solans M, Barceló MA, Morales-Suárez-Varela M. et al. Prenatal exposure to antibiotics and risk of childhood overweight or obesity: A systematic review and meta-analysis. Obes Rev 2022; 23 (Suppl. 01) e13382 DOI: 10.1111/obr.13382. (PMID: 34859947)
• 8 Bejaoui S, Poulsen M. The impact of early life antibiotic use on atopic and metabolic disorders: Meta-analyses of recent insights. Evol Med Public Health 2020; 2020: 279-289 DOI: 10.1093/emph/eoaa039. (PMID: 33324484)
• 9 Fan H, Gilbert R, O’Callaghan F. et al. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. BMJ 2020; 368: m331 DOI: 10.1136/bmj.m331.
• 10 Bai L, Zhao D, Cheng Q. et al. Trimester-specific association between antibiotics exposure during pregnancy and childhood asthma or wheeze: the role of confounding. Ann Epidemiol 2019; 30: 1-8 DOI: 10.1016/j.annepidem.2018.10.003. (PMID: 30448356)
• 11 Lee E, Cho J, Kim KY. The Association between Autism Spectrum Disorder and Pre- and Postnatal Antibiotic Exposure in Childhood-A Systematic Review with Meta-Analysis. Int J Environ Res Public Health 2019; 16: 4042 DOI: 10.3390/ijerph16204042. (PMID: 31652518)
• 12 Lavebratt C, Yang LL, Giacobini M. et al. Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study. Transl Psychiatry 2019; 9: 317 DOI: 10.1038/s41398-019-0653-9. (PMID: 31772217)
• 13 Zhuang C, Liao X, Fu M. et al. Association between the use of antibiotics during pregnancy and obesity in 5-year-old children. Transl Pediatr 2021; 10: 1686-1691 DOI: 10.21037/tp-21-220.
• 14 Parisi MA, Spong CY, Zajicek A. et al. We don’t know what we don’t study: the case for research on medication effects in pregnancy. Am J Med Genet C Semin Med Genet 2011; 157C: 247-250 DOI: 10.1002/ajmg.c.30309. (PMID: 21766436)
• 15 Charité-Universitätsmedizin Berlin. Embryotox – Arzneimittelsicherheit in Schwangerschaft und Stillzeit: Startseite. 26.03.2022 Accessed March 26, 2022 at: https://www.embryotox.de/
• 16 Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.. S2k-Leitlinie Antibiotikatherapie bei HNO-Infektionen [AWMF-Register-Nr. 017/066]. 2019 Accessed November 01, 2022 at: https://register.awmf.org/assets/guidelines/017–066l_S2k_Antibiotikatherapie_der_Infektionen_an_Kopf_und_Hals_2019–11_1.pdf
• 17 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). S3-Leitlinie: Therapie entzündlicher Brusterkrankungen in der Stillzeit [AWMF-Register Nr. 015/071]. 2013 Accessed November 01, 2022 at: https://register.awmf.org/assets/guidelines/015–071l_S3_Therapie_entzündlicher_Brustentzündungen_Stillzeit_2__2013–02-abgelaufen.pdf
• 18 Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. (PEG). S2k Leitlinie Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen [AWMF-Registernummer 082–006]. 2019 Accessed November 01, 2022 at: https://register.awmf.org/assets/guidelines/082–006l_S2k_Parenterale_Antibiotika_2019–08-abgelaufen.pdf
• 19 Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e. V.. Brennen beim Wasserlassen: S3-Leitlinie und Anwenderversion der S3-Leitlinie Harnwegsinfektionen. AWMF-Register-Nr. 053–001 DEGAM. 2018 Accessed November 01, 2022 at: https://register.awmf.org/assets/guidelines/053–001l_S3_Brennen_beim_Wasserlassen_2018–09-verlaengert_01.pdf
• 20 Thrane N, Olesen C, Schønheyder HC. et al. Socioeconomic factors and prescription of antibiotics in 0- to 2-year-old Danish children. J Antimicrob Chemother 2003; 51: 683-689 DOI: 10.1093/jac/dkg118. (PMID: 12615871)
• 21 Hulscher MEJL, van der Meer JWM, Grol RPTM. Antibiotic use: how to improve it?. Int J Med Microbiol 2010; 300: 351-356 DOI: 10.1016/j.ijmm.2010.04.003. (PMID: 20434950)
• 22 Eras P, Simões-Wüst AP, Thijs C. Influence of Alternative Lifestyles on Antibiotic Use during Pregnancy, Lactation and in Children. Antibiotics 2021; 10: 837 DOI: 10.3390/antibiotics10070837. (PMID: 34356758)
• 23 Rauh K, Kunath J, Rosenfeld E. et al. Healthy living in pregnancy: a cluster-randomized controlled trial to prevent excessive gestational weight gain – rationale and design of the GeliS study. BMC Pregnancy Childbirth 2014; 14: 119 DOI: 10.1186/1471-2393-14-119. (PMID: 24678761)
• 24 Weight Gain During Pregnancy: Reexamining the Guidelines. Rasmussen KM, Yaktine AL. Washington, DC: The National Academies Press; 2009. DOI: 10.17226/12584
• 25 Kunath J, Günther J, Rauh K. et al. Effects of a lifestyle intervention during pregnancy to prevent excessive gestational weight gain in routine care – the cluster-randomised GeliS trial. BMC Med 2019; 17: 5 DOI: 10.1186/s12916-018-1235-z.
• 26 Koletzko B, Bauer C-P, Bung P. et al. Ernährung in der Schwangerschaft – Teil 1. Dtsch Med Wochenschr 2012; 137: 1309-1314 DOI: 10.1055/s-0032-1305074.
• 27 Hoffmann J, Günther J, Stecher L. et al. Effects of a Lifestyle Intervention in Routine Care on Short- and Long-Term Maternal Weight Retention and Breastfeeding Behavior-12 Months Follow-up of the Cluster-Randomized GeliS Trial. J Clin Med 2019; 8: 876 DOI: 10.3390/jcm8060876. (PMID: 31248138)
• 28 Fahrmeir L, Kneib T, Lang S, Marx BD. Regression: Models, Methods and Applications. 2. Berlin: Springer Berlin; 2021
• 29 Padberg S, Schaefer C. Antiinfektiva während der Schwangerschaft und im Wochenbett. In: Friese K, Mylonas I, Schulze A. Infektionserkrankungen der Schwangeren und des Neugeborenen. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013: 111-125 DOI: 10.1007/978-3-540-78325-1_11
• 30 Mensah KB, Opoku-Agyeman K, Ansah C. Antibiotic use during pregnancy: a retrospective study of prescription patterns and birth outcomes at an antenatal clinic in rural Ghana. J Pharm Policy Pract 2017; 10: 24 DOI: 10.1186/s40545-017-0111-0. (PMID: 28808578)
• 31 Stokholm J, Schjørring S, Pedersen L. et al. Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS One 2013; 8: e82932 DOI: 10.1371/journal.pone.0082932.
• 32 Ruether K, Hösli I, Bitzer J. et al. Alltagsrelevante Infektionen von Schwangeren – Diagnostik und Therapie. Frauenheilkunde up2date 2009; 3: 273-288 DOI: 10.1055/s-0029-1224569.
• 33 Dashe JS, Gilstrap LC. Antibiotic use in pregnancy. Obstet Gynecol Clin North Am 1997; 24: 617-629 DOI: 10.1016/S0889-8545(05)70326-0. (PMID: 9266582)
• 34 Szweda H, Jóźwik M. Urinary tract infections during pregnancy – an updated overview. Dev Period Med 2016; 20: 263-272 (PMID: 28216479)
• 35 Lin CY, Hsu CH, Huang FY. et al. The changing face of early-onset neonatal sepsis after the implementation of a maternal group B Streptococcus screening and intrapartum prophylaxis policy--a study in one medical center. Pediatr Neonatol 2011; 52: 78-84 DOI: 10.1016/j.pedneo.2011.02.001. (PMID: 21524627)
• 36 Kwatra G, Cunnington MC, Merrall E. et al. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis 2016; 16: 1076-1084 DOI: 10.1016/S1473-3099(16)30055-X.
• 37 Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006; 107: 1120-1138 DOI: 10.1097/01.AOG.0000216197.26783.b5.
• 38 Bush K, Bradford PA. β-Lactams and β-Lactamase Inhibitors: An Overview. Cold Spring Harb Perspect Med 2016; 6: a025247 DOI: 10.1101/cshperspect.a025247. (PMID: 27329032)
• 39 Mangrio E, Wremp A, Moghaddassi M. et al. Antibiotic use among 8-month-old children in Malmö, Sweden--in relation to child characteristics and parental sociodemographic, psychosocial and lifestyle factors. BMC Pediatr 2009; 9: 31 DOI: 10.1186/1471-2431-9-31.
• 40 Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev 2009; (01) CD005458 DOI: 10.1002/14651858.CD005458.pub2. (PMID: 19160255)
• 41 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) e. V., Österreichische Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG), Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe. Sectio caesarea. AWMF-Registernummer 015–084 [S3-Leitlinie]. 2020 Accessed November 01, 2022 at: https://register.awmf.org/assets/guidelines/015–084l_S3_Sectio-caesarea_2020–06_1_02.pdf
• 42 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) e. V., Österreichische Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG), Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe. S2k-Leitlinie: Prävention und Therapie der Frühgeburt. 22.11.2022 Accessed January 29, 2023 at: https://register.awmf.org/de/leitlinien/detail/015–025